P002 Adjuvant chemotherapy for resected early-stage triple negative breast cancer
Main Authors: | C. Solinas, V. Bertaglia, M.C. Parati, K. Borgonovo, P. De Silva, A. Pretta, G. Saba, M. Migliari, F. Bardanzellu, S. Murgia, A.P. D’Agata, A. Cadoni, F. Contu, M. Cadeddu, G. Sanna, A. Luciani, S. Novello, M. Scartozzi, L.A. Emens, F. Petrelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623001212 |
Similar Items
-
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
by: Fausto Petrelli, et al.
Published: (2023-02-01) -
Fibroblast growth factor receptors as targets for anticancer therapy in cholangiocarcinomas and urothelial carcinomas
by: Demi Wekking, et al.
Published: (2023-09-01) -
Ribociclib in the Treatment of Hormone-Receptor Positive/HER2-Negative Advanced and Early Breast Cancer: Overview of Clinical Data and Patients Selection
by: Parati MC, et al.
Published: (2022-04-01) -
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
by: Pina Ziranu, et al.
Published: (2023-03-01) -
Immunonutrition supplementation for resectable gastric cancer during standard neoadjuvant chemotherapy of FLOT. A proof-of-concept protocol: I-SUPPLY
by: V. Pusceddu, et al.
Published: (2024-03-01)